Fascination About who makes copyright medication
U.S. pharma big copyright scrapped two experimental weight loss capsules last calendar year—a the moment-everyday capsule, lotiglipron, due to elevated liver enzymes plus a two times-day-to-day tablet, danuglipron, because of sturdy Unwanted side effects—but CEO Albert Bourla has said the company is determined to “Perform and acquire” from